文献速递胸部骨肌CT

无慢性阻塞性肺疾病人群的CT肺气肿与深度学习衍生椎体骨量丢失:MESA研究结果

CT Emphysema and Deep Learning-derived Vertebral Bone Loss in Individuals without COPD: Findings from MESA.
PubMed 文献 · Radiology · 2026-01-01

该研究二次分析MESA研究第5和第6次检查的胸部CT,用深度学习分割模型定量肺气肿百分比和胸椎骨密度,排除临床COPD者。横断面2312人、纵向1109人,肺气肿样改变百分比越高,骨密度越低且年骨量丢失越快,男性及黑种人/非裔美国人中关联显著,男性阈值超过2.7%肺气肿。

要点

  • 无COPD人群中,胸部CT定量的肺气肿样改变百分比越高,椎体骨密度越低且年丢失越快。
  • 男性年骨量丢失β=-0.38 mg/cm3/年(95%CI:-0.48,-0.28),黑种人/非裔美国人β=-0.24 mg/cm3/年(95%CI:-0.39,-0.09)。
  • 男性中肺气肿超过2.7%为骨密度下降阈值,对应39%的男性参与者。

核心结论

  • 无COPD个体中,较高肺气肿样改变百分比与更快的椎体骨量丢失独立相关,尤其在男性中,提示亚临床肺气肿可能是全身骨骼退化的新型影像标志物。

研究设计与样本

  • 前瞻性多种族MESA队列的第5和第6次检查胸部CT二次分析,采用SPIROMICS方案扫描,扫描时间为2010年4月至2018年3月;横断面分析2312人(中位年龄67岁,IQR 61-75岁;女性1285人),纵向分析1109人(中位年龄65岁,IQR 60-72岁;女性614人);肺气肿百分比在检查时量化,胸椎骨密度在两次检查时用经验证的深度学习分割模型评估;排除依据肺功能或自我报告确定的临床COPD者。

诊断标准与关键数值

  • 横断面分析:肺气肿样改变百分比越高与骨密度越低相关,β=-1.14 mg/cm3(95%CI:-1.76,-0.53)。
  • 纵向分析:肺气肿样改变百分比越高与年骨量丢失越大相关,β=-0.07 mg/cm3/年(95%CI:-0.13,-0.01)。
  • 交互效应:性别P<.001,种族或族裔P=.049。
  • 分层模型:男性β=-0.38 mg/cm3/年(95%CI:-0.48,-0.28),黑种人/非裔美国人β=-0.24 mg/cm3/年(95%CI:-0.39,-0.09)。
  • Johnson-Neyman法:男性中肺气肿超过2.7%为骨密度下降阈值,对应39%的男性参与者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background It is unknown whether subclinical emphysema-like changes, quantified at chest CT, are associated with loss of bone mineral density (BMD) in individuals without clinical chronic obstructive pulmonary disease (COPD). Purpose To identify early imaging markers of lung and bone health using deep learning-based imaging analysis in a large multiethnic cohort. Materials and Methods Chest CT scans obtained using the SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS) protocol during examination 5 and 6 of the prospective Multi-Ethnic Study of Atherosclerosis (MESA) were secondarily analyzed (April 2010-March 2018). Percentage emphysema was quantified at examination, and thoracic vertebral BMD was assessed at both examinations using a validated deep learning-based segmentation model. Participants with clinical COPD as determined on the basis of spirometry or self-reports were excluded. Linear mixed-effects models were constructed and adjusted for demographic characteristics and covariates, including smoking status, physical activity, and scanner type, and the interaction effect of sex was analyzed. Results The cross-sectional analysis included 2312 participants (median age, 67 years [IQR, 61-75 years]; 1285 female participants), and the longitudinal study included 1109 participants (median age, 65 years [IQR, 60-72 years]; 614 female participants) with available follow-up CT data. A greater percentage of emphysema-like changes was associated with lower BMD (β = -1.14 mg/cm3 [95% CI: -1.76, -0.53]) cross-sectionally and with greater annual BMD loss (β = -0.07 mg/cm3 per year [95% CI: -0.13, -0.01]) longitudinally. Interaction effects were identified for sex (P < .001) and race or ethnicity (P = .049). In stratified models, the associations were significant for men (β = -0.38 mg/cm3 per year [95% CI: -0.48, -0.28]) and Black/African American participants (β = -0.24 mg/cm3 per year [95% CI: -0.39, -0.09]). The Johnson-Neyman method revealed more than 2.7% emphysema as a threshold for a decrease in BMD among men, which corresponded to 39% of the male participants. The results remained robust after adjustment for pulmonary function and chronic respiratory symptoms. Conclusion In individuals without COPD, a greater percentage of emphysema-like changes was independently associated with faster vertebral bone loss, particularly in men, suggesting that subclinical emphysema may be a novel imaging marker of systemic skeletal decline. Clinical trial registration no. NCT0000548 © RSNA, 2026 Supplemental material is available for this article. See also the editorial by Fukuda in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Ghotbi E, Hathaway QA, Jannatdoust P, et al. CT Emphysema and Deep Learning-derived Vertebral Bone Loss in Individuals without COPD: Findings from MESA. Radiology. 2026. PMID: 42012343. doi:10.1148/radiol.252251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。